Maintenance / Service
PRODUCTS
-
Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Capture data at the true source: the patient. Improve the patient experience with secure, accessible questionnaires both via email and through the Castor Connect mobile application.
-
Digitize batch records to eliminate paper, reduce errors, and accelerate execution.
-
PHCbi brand’s 25.6 cu.ft (725L) FrostLess ultra-low temperature freezer provides reliable temperatures as low as -86°C. It is engineered to mitigate frost buildup more than our category-leading models while maintaining the reliability and energy efficiency that today's laboratories require. It operates on 115V and uses only 7.9kWh per day. ENERGY STAR® Certified.
WHITE PAPERS AND CASE STUDIES
-
Inside A Collaboration To Design Cutting Edge Modular Cleanrooms
Learn about a collaboration that has yielded advanced modular cleanrooms, integrating cutting-edge building automation, critical monitoring, and data aggregation for manufacturing intelligence.
-
Digital Standardization: Accelerating Gene Therapy Tech Transfer With Confidence And Compliance
Fragmented, manual data practices slow tech transfer and increase risk; centralized digital CMC systems standardize workflows, improve transparency, and accelerate onboarding while maintaining compliance.
-
Inline Checkweighing Of Packaged Products In Manufacturing
Accurate inline checkweighing is vital for quality control. Learn how system design, software, and regulatory compliance work together to overcome high-speed production challenges.
-
Rapid And Robust Preclinical And Clinical Development Of CAR T-Cell Therapies
Streamline CAR T-cell therapy development with integrated support for asset identification, IND submission, early-phase studies, and advanced real-time tracking solutions.
-
Forget About Isolators: Switching From Manual Vial To Automated Bag Filling
Discover how transitioning from manual vial filling to single-use bag systems can reduce contamination risk, improve accuracy, and enhance GMP compliance in biopharmaceutical manufacturing.
-
MilliporeSigma's 97-Day Implementation Success Story
Read how MilliporeSigma transformed validation processes with a digital validation system to achieve compliance in just 97 days, as well as learn key takeaways from their swift transition.
-
Outgrowing Excel: Implementing RTSM Software In A Live Phase I Trial
Moving from manual spreadsheets to RTSM mid-study requires precision. Learn how clinical teams maintain trial momentum while executing protocol changes without delays.
-
AMR Drives Exeter-Merritt Growing Water Network
Located in the state of Illinois, Exeter-Merritt Water Cooperative delivers safe and high-quality drinking water to approximately 300 residents from the county of Scott and Morgan. In 2011, the cooperative decided to do a phase 3 expansion and include additional homes in the rural area resulting in connections increasing from 154 to 325. Exeter and Merritt are small rural towns built on hilly terrains and gravel roads, with most of the meters installed in the countryside.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Outgrowing Excel: Implementing RTSM In A Live Phase I Trial
Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
Leading Recruitment With A Strong Alzheimer's Referral Pool
A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
NEWS
-
Shimadzu Introduces i-Series LC-2070/LC-2080 Integrated HPLC Systems11/10/2025
Shimadzu Scientific Instruments announces the launch of the i-Series LC-2070/LC-2080 Integrated High-Performance Liquid Chromatographs (HPLC), the latest evolution of its i-Series line.
-
Wayvia Unveils New MCP-Powered Innovations To Help Brands Unlock Smarter Commerce Intelligence8/28/2025
Wayvia, the omnicommerce enablement leader formerly known as PriceSpider, today announced a series of new MCP-powered product innovations previewing the next wave of AI-driven commerce intelligence.
-
Simbe Expands Next-Generation Computer Vision Technology To Transform Retail Execution5/20/2025
Simbe, the global leader in shelf digitization, today announced significant advancements to Simbe Vision™, its AI-powered computer vision (CV) technology, further solidifying the company's position as the retail industry's most advanced in-store intelligence solution.
-
Grifols And Inpeco Joining Forces To Deliver Transfusion Medicine 'Lab Of The Future'3/20/2025
Grifols a global healthcare company and leading manufacturer of plasma-derived medicines and innovative diagnostic solutions, today announced it has signed a strategic agreement with Inpeco, a global leader in total laboratory automation technologies, to provide transfusion medicine labs with complete, tailored instrumentation, robotics and software capabilities to modernize their operations and make them more efficient.
-
ITM And Alpha-9 Oncology Enter Into Supply Agreement For Therapeutic Medical Radioisotope Actinium-2254/24/2025
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical-stage biotechnology company advancing a distinctive portfolio of differentiated and highly targeted radiopharmaceuticals, today announced the signing of a supply agreement for Actinium-225 (Ac-225) to support the development of Alpha-9’s radiopharmaceutical programs.